saflutan 15 microgrammes/ml, collyre en solution en récipient unidose
laboratoires santen oy - tafluprost - collyre - 15 microgrammes - composition pour 1 ml > tafluprost : 15 microgrammes - antiglaucomateux et myotiques, analogues des prostaglandines
saflutan unidose de collyre
santen sa - tafluprostum - unidose de collyre - tafluprostum 15 µg, glycerolum, natrii dihydrogenophosphas dihydricus corresp. phosphas 1.2 mg, dinatrii edetas, polysorbatum 80, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - glaucome - synthetika
saflutan collyre (multidose)
santen sa - tafluprostum - collyre (multidose) - tafluprostum 15 µg, glycerolum, natrii dihydrogenophosphas dihydricus corresp. phosphas 1.2 mg, dinatrii edetas, polysorbatum 80, natrii hydroxidum aut acidum hydrochloridum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - glaucome - synthetika
saflutan 15 µg/ml collyre sol. flac. compte-gouttes récip. unidose
santen oy - tafluprost 0,015 mg/ml - collyre en solution - 15 µg/ml - tafluprost 15 µg/ml - tafluprost
saflutan 15 µg/ml collyre sol. flac. compte-gouttes récip. unidose
santen oy - tafluprost 0,015 mg/ml - collyre en solution - tafluprost
saflutan solution
purdue pharma - tafluprost - solution - 4.5mcg - tafluprost 4.5mcg - prostaglandin analogs
tafluprost santen 15 mcg / ml unidose de collyre
santen sa - tafluprostum - unidose de collyre - tafluprostum 15 µg, glycerolum, natrii dihydrogenophosphas dihydricus corresp. phosphas 1.2 mg, dinatrii edetas, polysorbatum 80, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - glaucome - synthetika